| Institution: | 1. Division of Nephrology, Johns Hopkins University , Baltimore, MD, US  https://orcid.org/0000-0002-0728-8436;2. Division of Pediatric Nephrology, Johns Hopkins University , Baltimore, MD, US;3. Division of Nephrology, Johns Hopkins University , Baltimore, MD, US;4. Division of Infectious Disease, Johns Hopkins University , Baltimore, MD, US https://orcid.org/0000-0002-3013-4339 |
| Abstract: | ABSTRACT Introduction Since the developmentof combined antiretroviral therapy (cART), HIV-associated mortality and the incidence of HIV-associated end-stage kidney disease (ESKD) has decreased. However, in the United States, an increase in non-HIV-associated kidney diseases within the HIV-positive population is expected. |
![ORCID Icon]({"type":"image","src":"/templates/jsp/images/orcid.png"} "ORCID Icon")
https://orcid.org/0000-0002-0728-8436;2. Division of Pediatric Nephrology, Johns Hopkins University , Baltimore, MD, US;3. Division of Nephrology, Johns Hopkins University , Baltimore, MD, US;4. Division of Infectious Disease, Johns Hopkins University , Baltimore, MD, US